PPT-Value-Based Pricing for Drugs with Accelerated Approval Incorporating Uncertainty and

Boshen Jiao PhD MPH Harvard TH Chan School of Public Health Acknowledgement Collaborators Stéphane Verguet PhD MPP Harvard Yuli Lily Hsieh MPH Harvard Disclosure No funding support and conflict of interest related to this study. aversion in models of regretful and noisy behavior Abstract Substantial evidence has accumulated in recent empirical works on the limited ability of the Nash equilibrium to rationalize observed beha Charles . Noussair. , Stefan . Trautmann. , . Gijs. van de . Kuilen. , and Nathanael . Vellekoop. Tilburg University. Risk and Choice: Conference in honor of Louis . Eeckhoudt. Toulouse, 2012 . W. e . Batten Disease. June 29-30, 2010 . FDA Public Meeting. “Considerations regarding the review and . regulation of articles for treatment of rare diseases”. Tracy VanHoutan, . Board Member . of the Batten Disease Support and Research Association (BDSRA). models of . PG:. Risk preference and delay . discounting. Kate . Lomakina. 9. November 2012 . Outline. Risk aversion. Expected value vs. expected utility . theory . R. isk. -. taking models. Risk perception . Pricing in Commercial Banking. April 2015. 2. Confidentiality. Our clients’ industries are extremely competitive. The confidentiality of companies’ plans and data is obviously critical. ICG will protect the confidentiality of all such client information. Similarly, management consulting is a competitive business. We view our approaches and insights as proprietary and therefore look to our clients to protect ICG’s interests in our proposals, presentations, methodologies and analytical techniques. Under no circumstances should this material be shared with any third party without the explicit written permission of ICG.. Introduction. Indian Pharmaceutical industry is driven by knowledge,skills,low cost of production and international quality products. Indian . pharma. industry has witnessed rapid growth . Introduction. Indian Pharmaceutical industry is driven by knowledge,skills,low cost of production and international quality products. Indian . pharma. industry has witnessed rapid growth . A Systematic Review of the Literature. Cindy Jardine. University of Alberta. S. Michelle Driedger. University of Manitoba. Study Objectives. To evaluate empirical studies of communicating uncertainty . Heisenberg. Causality law has it that if we know the present, then we can predict the future.. Be aware: in this formulation, it is not the consequence, but the premise, that is false. As a matter of principle, we cannot know all determining elements of the present.. Richard Judson. U.S. EPA, National Center for Computational Toxicology. Office of Research and Development. The views expressed in this presentation are those of the author and do not necessarily reflect the views or policies of the U.S. EPA. Uncertainty. Irreducible uncertainty . is inherent to a system. Epistemic uncertainty . is caused by the subjective lack of knowledge by the algorithm designer. In optimization problems, uncertainty can be represented by a vector of random variables . Economic Behavior & Organization Manuscript Draft Manuscript Number: JEBO - D - 18 - 00695 Title: Risk and ambiguity aversion behaviour in index - based insurance uptake decisions: experimental evide trengthening the Accelerated Approval Pathway1STRENGTHENING THE ACCELERATED APPROVAL PATHWAYAN ANALYSIS OF POTENTIAL POLICY REFORMS AND THEIR IMPACT ON UNCERTAINTYACCESS INNOVATION AND COSTSApril26 20 1. ERiMA. : . Envisioning Risk Models for Assessment of AI-based applications.. 2. Dr Huma Samin. 1. Post Doctoral Research Associate Computer Science. Durham University, UK. huma.samin@durham.ac.uk.